Company Search:
Advanced Search
Sponsored Links
Novartis AG Company Snapshot
Novartis AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novartis with three other pharmaceutical manufacturers in Europe: Bayer AG of GERMANY (2020 sales of 41.40 billion Euros [US$48.94 billion] of which 46% was CropScience), Sanofi S.A. of FRANCE (37.37 billion Euros [US$44.17 billion] of which 69% was Pharmaceuticals), and GlaxoSmithKline plc which is based in UNITED KINGDOM (£34.10 billion [US$47.16 billion] of which 50% was Pharmaceuticals).

Sales Analysis. During the second quarter of 2021, sales at Novartis totalled 12.13 billion Swiss Francs. This is an increase of 11.8% from the 10.85 billion Swiss Francs in sales at the company during the second quarter of 2020. This was the biggest same quarter rise in sales at Novartis in the previous 35 quarters. During the first two quarters of 2021, sales totalled 23.73 billion Swiss Francs, which is 4.5% higher than through the first two quarters of 2020. Novartis reported sales of 46.58 billion Swiss Francs (US$50.63 billion) for the year ending December of 2020. This represents a decrease of 3.6% versus 2019, when the company's sales were 48.29 billion Swiss Francs. The sales level in 2020 was fairly close to the level five years ago: in 2015, Novartis had sales of 48.55 billion Swiss Francs. Contributing to the drop in overall sales was the 6.8% decline in Sandoz, from 9.66 billion Swiss Francs to 9.00 billion Swiss Francs. There were also decreases in sales in Innovative Medicines (down 3.3% to 36.42 billion Swiss Francs) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Novartis AG
  Stock Performance Chart for Novartis AG
  Stock Data: Recent Stock Performance:
  Current Price (9/10/2021): 78.67
(Figures in Swiss Francs)
1 Week -5.6%   13 Weeks -8.5%  
4 Weeks -5.6%   52 Weeks -3.8%  
Novartis AG Key Data:
  Ticker: NOVN Country: Switzerland
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 46,575,791,160
(Year Ending Jan 2021).
Employees: 105,794
  Currency: Swiss Francs Market Cap: 175,964,260,041
  Fiscal Yr Ends: December Shares Outstanding: 2,236,739,037
  Share Type: Namenaktie Closely Held Shares: 90,053,616
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.